Endogenous aldosterone is involved in vascular calcification in rat

Experimental Biology and Medicine

Volumn 237, Issue 1, 2012, Pages 31-37

  Wu, Sheng Ying ^a   Yu, Yan Rong ^a   Cai, Yan ^a   Jia, Li Xin ^b   Wang, Xiong ^a   Xiao, Chuan Shi ^b   Tang, Chao Shu ^a   Qi, Yong Fen ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Aldosterone; Blood vessel; Calcification; Fibrosis; Rat

Indexed keywords

ALDOSTERONE; ALKALINE PHOSPHATASE; ANGIOTENSIN II; CALCIUM; CAPTOPRIL; COLLAGEN; MESSENGER RNA; OSTEOPONTIN; SPIRONOLACTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; BIOACCUMULATION; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALDOSTERONE; ALDOSTERONE ANTAGONISTS; ALKALINE PHOSPHATASE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; CALCIUM; CAPTOPRIL; CHOLECALCIFEROL; COLLAGEN; FIBROSIS; HYPERTENSION; MALE; NICOTINE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPIRONOLACTONE; VASCULAR CALCIFICATION;

RATTUS;

EID: 84862914035     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011175     Document Type: Article

References (32)

1. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008;117:2938-2948.
2. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006;99:1044-1059.
3. Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 2010;7:528-536.
4. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006;26:1423-1430.
5. Cai Y, Teng X, Pan CS, Duan XH, Tang CS, Qi YF. Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin 2010;31:1359-1366.
6. Essalihi R, Ouellette V, Dao HH, McKee MD, Moreau P. Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin? J Cardiovasc Pharmacol 2004;44:S147-S150.
7. Huang Z, Li J, Jiang Z, Qi Y, Tang C, Du J. Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 2003;42:89-97.
8. Qiao W, Chaoshu T, Hongfang J, Junbao D. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun 2010;396:182-186.
9. Zhang B, Wang S, Pang Y, Tang C, Du J. Alteration of heme-oxygenase-carbon monoxide pathway in calcified rat vascular smooth muscle cells. Z Kardiol 2004;93:109-115.
10. Kanno Y, Into T, Lowenstein CJ, Matsushita K. Nitric oxide regulates vascular calcification by interfering with TGF-signalling. Cardiovasc Res 2008;77:221-230.
11. Chrysant SG, Chrysant GS, Chrysant C, Shiraz M. The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Curr Clin Pharmacol 2010;5:89-95.
12. Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 2010;6:261-273.
13. Jaffe IZ, Mendelsohn ME. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 2005;96:643-650.
14. Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 2007;27:799-805.
15. Niederhoffer N, Bobryshev YV, Lartaud-Idjouadiene I, Giummelly P, Atkinson J. Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res 1997;34:386-398.
16. Cai DY, Yu F, Jiang W, Jiang HF, Pan CS, Qi YF, Chang L, Zhao J, Yang JH, Zhu MJ, Jia YX, Geng B, Ma TM, Pang YZ, Tang CS. Adrenomedullin(27-52) inhibits vascular calcification in rats. Regul Pept 2005;129:125-132.
17. Takeda R, Hatakeyama H, Takeda Y, Iki K, Miyamori I, Sheng WP, Yamamoto H, Blair IA. Aldosterone biosynthesis and action in vascular cells. Steroids 1995;60:120-124.
18. Duprez DA. Aldosterone and the vasculature: mechanisms mediating resistant hypertension. J Clin Hypertens (Greenwich) 2007;9:13-18.
19. Rocha R, Stier CT Jr. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001;12:308-314.
20. Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Bornstein SR, Willenberg HS. Endothelial cell-mediated regulation of aldosterone release from human adrenocortical cells. Mol Cell Endocrinol 2007;265-266:150-156.
21. Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 2005;186:1-20.
22. Lai L, Pen A, Hu Y, Ma J, Chen J, Hao CM, Gu Y, Lin S. Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor. Life Sci 2007;81:570-576.
23. Struthers AD, MacDonald TM. Review of aldosterone- and angiotensin II-induced target organ damage and prevention. Cardiovasc Res 2004;61:663-670.
24. Gekle M, Grossmann C. Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly? Pflugers Arch 2009;458:231-246.
25. Funder JW, Reincke M. Aldosterone: a cardiovascular risk factor? Biochim Biophys Acta 2010;1802:1188-1192.
26. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002;40:504-510.
27. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871-878.
28. Oberleithner H, Ludwig T, Riethmüller C, Hillebrand U, Albermann L, Schäfer C, Shahin V, Schillers H. Human endothelium: target for aldosterone. Hypertension 2004;43:952-956.
29. Hillebrand U, Schillers H, Riethmüller C, Stock C, Wilhelmi M, Oberleithner H, Hausberg M. Dose-dependent endothelial cell growth and stiffening by aldosterone: endothelial protection by eplerenone. J Hypertens 2007;25:639-647.
30. Schiffrin EL, Touyz RM. Calcium, magnesium, and oxidative stress in hyperaldosteronism. Circulation 2005;111:830-831.
31. Quaschning T, Ruschitzka F, Shaw S, Lüscher TF. Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension. Hypertension 2001;37:801-805.
32. Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res 2005;97:434-442